AACR President David A. Tuveson, MD, PhD, FAACR, uses Wayne Gretzky’s predictive approach to playing hockey as an example for how the cancer community could meet President Biden’s goal of reducing cancer mortality by 50 percent in the next 25 years.

Camille C. R. Ragin, PhD, MPH, led a Saturday afternoon Educational Session that examined how implementation science can be leveraged to address problems that have contributed to health inequities in cancer research and care in the U.S. and abroad.

Annual Meeting Program Committee Chair Marcia R. Cruz-Correa, MD, PhD, shares a few highlights from Sunday’s schedule to help plan your day.

Three researchers, including session chair Kathy McCoy, PhD, discussed the links between dietary modification of the microbiome and response to immunotherapy during a Friday afternoon Educational Session.

Jiaoti Huang, MD, PhD, was one of three pathologists who discussed how advances in technology are improving the accuracy and specificity of tumor assessment during a Saturday morning session.

The quest to overcome drug resistance is inextricably linked to Joseph R. Bertino, MD, FAACR, who helped define the mechanisms of action and resistance to one of the most important cancer chemotherapy agents, methotrexate.

Three experts, including H. Courtney Hodges, PhD, provided an update on emerging concepts and technologies to visualize tumor biology during a Saturday morning Educational Session.